Most Popular
Newsletter
COVID-19
Cyagen to Remain Fully Operational Throughout COVID-19
Apr 27, 2020
Despite the effects of COVID-19 on global business, we are operating at 100% proficiency - providing uninterrupted production and technical support to ensure that your research continues. We will continue serving your model generation, cloning, and virus packaging needs with the same high quality and fast turnaround as before the outbreak. Read More >
Research Trend
White Paper
COVID-19
Complete Collection: The Hottest Mouse Models for Coronavirus Research
Apr 10, 2020
The World Health Organization (WHO) announced the reclassification of the COVID-19 outbreak as a global pandemic on March 11, 2020. With the rapid spread of the disease across the globe, countries worldwide have joined the war against the SARS-CoV-2 virus, for which, early prevention, control, and treatment may provide valuable tools against the pandemic. Read More >
Newsletter
Research Trend
COVID-19
Beyond Mediating Host Cell Entry of SARS-CoV-2: What Roles Does ACE2 Play?
Apr 01, 2020
In our fight against the virus and COVID-19, researchers have studied the SARS-CoV-2 virus itself and its host receptor, ACE2, from the aspects of epidemiology, pathology, virus traceability, prevention, and control measures. The human ACE2 receptor is known to interact with SARS-CoV-2 and permit its initial cell entry, making it particularly important to explore its function. Read More >
Newsletter
COVID-19
Interview: Impact of COVID-19 Respiratory Illness on the Life Science Research Industry
Mar 20, 2020
With the gradual improvement of the COVID-19 situation in China in the past few days, along with a worsening situation across many regions, research on vaccines and related antiviral drugs has become a key issue for most people both inside and outside the life science research industry. Read More >
Newsletter
Research Trend
COVID-19
Cytokine Storm: The New Perspective for COVID-19 Research
Mar 19, 2020
Since COVID-19 poses a significant threat to public health and also represents a challenge for antiviral drug development and administration globally, current efforts focus on prevention and control while accelerating the research on the SARS-CoV-2 coronavirus, which has caused the outbreak of COVID-19. Read More >
Newsletter
Research Trend
White Paper
COVID-19
Researching the New Coronavirus, SARS-CoV-2: Applications for Animal Models
Mar 10, 2020
The novel coronavirus, now officially designated as SARS-CoV-2, was first identified in Wuhan, Hubei Province, China in December of 2019. This virus has led to an outbreak of COVID-19 (Coronavirus Disease in 2019), which is associated with acute respiratory illness and infection, as is common for diseases caused by the coronavirus family. Read More >
Research Trend
Breaking News
White Paper
COVID-19
Coronaviruses and SARS-CoV-2 – Host Receptor-Mediated Infection Mechanisms & Potential Antiviral Treatments
Mar 10, 2020
At the end of 2019, a large-scale illness broke out from Wuhan, Hubei Province - a central province of China. The virus that cased this illness could enter the respiratory tract through droplets - moreover, the increasingly busy traffic conditions and travel around the holiday season made the virus spread extremely rapidly. Read More >
Research Trend
Breaking News
White Paper
COVID-19
Beyond ACE2: Additional Targets of Significance for Coronavirus Research
Mar 10, 2020
At present, the prevention and treatment of coronavirus is the most urgent issue for scientific and medical research. In addition to the ACE2 host receptor target that is being highly focused on, what other targets deserve the attention of current coronavirus researchers? Read More >
Research Trend
Breaking News
White Paper
COVID-19
White Paper: Infectivity and Immune Mechanisms of Coronaviruses & SARS-CoV-2
Feb 27, 2020
An outbreak of COVID-19 (Coronavirus Disease in 2019) caused by the novel coronavirus, officially named SARS-CoV-2, swept across the world from Wuhan at the end of 2019 - having since brought a huge impact on the lives of people both in China and abroad. Read More >